Experiment 334399

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

DAUNORUBICIN

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeSC
OrganismEmpty organism
CitationFURUSAWA,E: SUZUKI,M: FURUSAWA,S: LEE,JYB:. (1975). COMBINATION CHEMOTHERAPY OF RAUSCHER LEUKEMIA AND ASCITES TUMORS BY NARCISSUS ALKALOID WITH STANDARD DRUGS AND EFFECT ON CELLULAR IMMUNITY (38896).. 149()
Amount utilized
Compound isolated
Disease+ PRETAZETTINE(25 MG/KG)
Dose amount0.25 MG
Number19
Percent yield77%
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE
Expression resultILS